Cargando…
Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury
Damage to long axons in white matter tracts is a major pathology in closed head traumatic brain injury (TBI). Acute TBI treatments are needed that protect against axon damage and promote recovery of axon function to prevent long term symptoms and neurodegeneration. Our prior characterization of axon...
Autores principales: | Radomski, Kryslaine L., Zi, Xiaomei, Lischka, Fritz W., Noble, Mark D., Galdzicki, Zygmunt, Armstrong, Regina C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059462/ https://www.ncbi.nlm.nih.gov/pubmed/35501931 http://dx.doi.org/10.1186/s40478-022-01366-z |
Ejemplares similares
-
Experimental Traumatic Brain Injury Identifies Distinct Early and Late Phase Axonal Conduction Deficits of White Matter Pathophysiology, and Reveals Intervening Recovery
por: Marion, Christina M., et al.
Publicado: (2018) -
Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures
por: Bradshaw, Donald V., et al.
Publicado: (2021) -
Neuroprotective Properties of 4-Aminopyridine
por: Dietrich, Michael, et al.
Publicado: (2021) -
Repetitive Blast Exposure Produces White Matter Axon Damage without Subsequent Myelin Remodeling: In Vivo Analysis of Brain Injury Using Fluorescent Reporter Mice
por: Bradshaw, Donald V., et al.
Publicado: (2021) -
Dynamics of aminopyridine block of potassium channels in squid axon membrane
Publicado: (1976)